General Information of Drug Off-Target (DOT) (ID: OT9EIUGH)

DOT Name Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL)
Gene Name PHYHIPL
Related Disease
Glioblastoma multiforme ( )
Glioma ( )
UniProt ID
PHIPL_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00041 ; PF19281
Sequence
MEVPRLDHALNSPTSPCEEVIKNLSLEAIQLCDRDGNKSQDSGIAEMEELPVPHNIKISN
ITCDSFKISWEMDSKSKDRITHYFIDLNKKENKNSNKFKHKDVPTKLVAKAVPLPMTVRG
HWFLSPRTEYTVAVQTASKQVDGDYVVSEWSEIIEFCTADYSKVHLTQLLEKAEVIAGRM
LKFSVFYRNQHKEYFDYVREHHGNAMQPSVKDNSGSHGSPISGKLEGIFFSCSTEFNTGK
PPQDSPYGRYRFEIAAEKLFNPNTNLYFGDFYCMYTAYHYVILVIAPVGSPGDEFCKQRL
PQLNSKDNKFLTCTEEDGVLVYHHAQDVILEVIYTDPVDLSVGTVAEITGHQLMSLSTAN
AKKDPSCKTCNISVGR
Function May play a role in the development of the central system.

Molecular Interaction Atlas (MIA) of This DOT

2 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Glioblastoma multiforme DISK8246 Strong Biomarker [1]
Glioma DIS5RPEH Strong Biomarker [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL). [2]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL). [3]
Quercetin DM3NC4M Approved Quercetin decreases the expression of Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL). [4]
Triclosan DMZUR4N Approved Triclosan decreases the expression of Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL). [5]
Cytarabine DMZD5QR Approved Cytarabine increases the expression of Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL). [6]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL). [7]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL). [9]
Bisphenol A DM2ZLD7 Investigative Bisphenol A affects the expression of Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL). [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL). [8]
------------------------------------------------------------------------------------

References

1 Phytanoyl-CoA 2-Hydroxylase-Interacting Protein-Like Gene Is a Therapeutic Target Gene for Glioblastoma Multiforme.Med Sci Monit. 2019 Apr 9;25:2583-2590. doi: 10.12659/MSM.913895.
2 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
3 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
4 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
5 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
6 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
7 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
8 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
9 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
10 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.